A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
Public ClinicalTrials.gov record NCT05084963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Double-blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of IRL201104 in Adult Participants With Active Eosinophilic Esophagitis (EoE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to asses the efficacy, safety and tolerability of repeat doses of IRL201104 in Adult Participants with Active Eosinophilic Esophagitis (EoE)
Study identification
- NCT ID
- NCT05084963
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2021 (Actual)
- Primary completion
- Oct 24, 2022 (Actual)
- Completion
- Oct 24, 2022 (Actual)
- Last update posted
- May 21, 2025
2021 – 2022
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Revolo Investigational Site | Little Rock | Arkansas | 72211 | — |
| Revolo Investigational Site | Murrieta | California | 92563 | — |
| Revolo Investigational Site | Centennial | Colorado | 80112 | — |
| Revolo Investigational Site | New Port Richey | Florida | 34653 | — |
| Revolo Investigational Site | Orlando | Florida | 32825 | — |
| Revolo Investigational Site | Sandy Springs | Georgia | 30328 | — |
| Revolo Investigational Site | Iowa City | Iowa | 52242 | — |
| Revolo Investigational Site | Crowley | Louisiana | 70526 | — |
| Revolo Investigational Site | Marrero | Louisiana | 70072 | — |
| Revolo Investigational Site | Boston | Massachusetts | 02111 | — |
| Revolo Investigational Site | Boston | Massachusetts | 02114 | — |
| Revolo Investigational Site | Farmington Hills | Michigan | 48334 | — |
| Revolo Investigational Site | Great Neck | New York | 11021 | — |
| Revolo Investigational Site | Chapel Hill | North Carolina | 27599 | — |
| Revolo Investigational Site | Durham | North Carolina | 27710 | — |
| Revolo Investigational Site | Raleigh | North Carolina | 27607 | — |
| Revolo Investigational Site | Mentor | Ohio | 44060 | — |
| Revolo Investigational Site | Chattanooga | Tennessee | 37421 | — |
| Revolo Investigational Site | Kingsport | Tennessee | 37663 | — |
| Revolo Investigational Site | Baytown | Texas | 77521 | — |
| Revolo Investigational Site | Harlingen | Texas | 78550 | — |
| Revolo Investigational Site | Riverton | Utah | 84065 | — |
| Revolo Investigational Site | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05084963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2025 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05084963 live on ClinicalTrials.gov.